Attached files
| file | filename |
|---|---|
| EX-32.1 - Cocrystal Pharma, Inc. | ex32-1.htm |
| EX-31.2 - Cocrystal Pharma, Inc. | ex31-2.htm |
| EX-31.1 - Cocrystal Pharma, Inc. | ex31-1.htm |
| EX-21.1 - Cocrystal Pharma, Inc. | ex21-1.htm |
| EX-4.1 - Cocrystal Pharma, Inc. | ex4-1.htm |
| 10-K - Cocrystal Pharma, Inc. | form10-k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Cocrystal Pharma, Inc.
Bothell, Washington
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-220632) and Form S-8 (No. 333-193161 and No. 333-224869) of Cocrystal Pharma, Inc. of our report dated March 27, 2020, relating to the consolidated financial statements, which appear in this Form 10-K.
| /s/ Weinberg & Company | |
| Los Angeles, California | |
| March 27, 2020 | |